Your browser doesn't support javascript.
loading
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome.
Crosbie, Emma J; Ryan, Neil A J; Arends, Mark J; Bosse, Tjalling; Burn, John; Cornes, Joanna M; Crawford, Robin; Eccles, Diana; Frayling, Ian M; Ghaem-Maghami, Sadaf; Hampel, Heather; Kauff, Noah D; Kitchener, Henry C; Kitson, Sarah J; Manchanda, Ranjit; McMahon, Raymond F T; Monahan, Kevin J; Menon, Usha; Møller, Pål; Möslein, Gabriela; Rosenthal, Adam; Sasieni, Peter; Seif, Mourad W; Singh, Naveena; Skarrott, Pauline; Snowsill, Tristan M; Steele, Robert; Tischkowitz, Marc; Evans, D Gareth.
Affiliation
  • Crosbie EJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK. Emma.crosbie@manchester.ac.uk.
  • Ryan NAJ; Directorate of Gynaecology, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. Emma.crosbie@manchester.ac.uk.
  • Arends MJ; Prevention Early Detection Theme, NIHR Biomedical Research Centre, The Christie NHS Foundation Trust, Manchester, UK. Emma.crosbie@manchester.ac.uk.
  • Bosse T; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.
  • Burn J; Division of Evolution and Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester, UK.
  • Cornes JM; Division of Pathology & Centre for Comparative Pathology, Cancer Research UK Edinburgh Centre, Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK.
  • Crawford R; Pathology Department, Leiden University Medical Center, Leiden, the Netherlands.
  • Eccles D; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Frayling IM; Patient Representative, Cambridge, UK.
  • Ghaem-Maghami S; Department of Gynaecological Oncology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Hampel H; Faculty of Medicine, University of Southampton, University Hospital Southampton, Southampton, UK.
  • Kauff ND; Institute of Cancer and Genetics, Cardiff University, Cardiff, UK.
  • Kitchener HC; Department of Surgery and Cancer, Imperial College, London, UK.
  • Kitson SJ; Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Manchanda R; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
  • McMahon RFT; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.
  • Monahan KJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.
  • Menon U; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Møller P; Department of Histopathology, Manchester University NHS Foundation Trust, Manchester, UK.
  • Möslein G; Chelsea & Westminster Hospital NHS Trust, London, UK.
  • Rosenthal A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
  • Sasieni P; Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Oslo, Norway.
  • Seif MW; Research Group Inherited Cancer, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
  • Singh N; Center for Hereditary Tumors, Helios University Hospital Wuppertal, University of Witten-, Herdecke, Germany.
  • Skarrott P; Center for Hereditary Tumors, Helios University Hospital Wuppertal, University of Witten-, Herdecke, Germany.
  • Snowsill TM; Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, London, UK.
  • Steele R; School of Cancer and Pharmaceutical Sciences, Kings College London, London, UK.
  • Tischkowitz M; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.
  • Evans DG; Department of Cellular Pathology, Barts Health NHS Trust, London, UK.
Genet Med ; 21(10): 2390-2400, 2019 10.
Article in En | MEDLINE | ID: mdl-30918358
ABSTRACT

PURPOSE:

There are no internationally agreed upon clinical guidelines as to which women with gynecological cancer would benefit from Lynch syndrome screening or how best to manage the risk of gynecological cancer in women with Lynch syndrome. The Manchester International Consensus Group was convened in April 2017 to address this unmet need. The aim of the Group was to develop clear and comprehensive clinical guidance regarding the management of the gynecological sequelae of Lynch syndrome based on existing evidence and expert opinion from medical professionals and patients.

METHODS:

Stakeholders from Europe and North America worked together over a two-day workshop to achieve consensus on best practice.

RESULTS:

Guidance was developed in four key areas (1) whether women with gynecological cancer should be screened for Lynch syndrome and (2) how this should be done, (3) whether there was a role for gynecological surveillance in women at risk of Lynch syndrome, and (4) what preventive measures should be recommended for women with Lynch syndrome to reduce their risk of gynecological cancer.

CONCLUSION:

This document provides comprehensive clinical guidance that can be referenced by both patients and clinicians so that women with Lynch syndrome can expect and receive appropriate standards of care.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms, Hereditary Nonpolyposis / Endometrial Neoplasms / Genital Neoplasms, Female Type of study: Diagnostic_studies / Guideline / Screening_studies Limits: Female / Humans Country/Region as subject: America do norte / Europa Language: En Journal: Genet Med Journal subject: GENETICA MEDICA Year: 2019 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms, Hereditary Nonpolyposis / Endometrial Neoplasms / Genital Neoplasms, Female Type of study: Diagnostic_studies / Guideline / Screening_studies Limits: Female / Humans Country/Region as subject: America do norte / Europa Language: En Journal: Genet Med Journal subject: GENETICA MEDICA Year: 2019 Document type: Article Affiliation country: United kingdom